These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37833694)

  • 1. Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis and in vivo experiment.
    Zeng LP; Qin YQ; Lu XM; Feng ZB; Fang XL
    World J Surg Oncol; 2023 Oct; 21(1):324. PubMed ID: 37833694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Methoxydalbergione Elicits Anticancer Effects by Upregulation of GADD45G in Human Liver Cancer Cells.
    Zeng L; Qin Y; Lu X; Fang X; Huang J; Yu C; Feng ZB
    J Healthc Eng; 2023; 2023():6710880. PubMed ID: 36776954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIP1 is a downstream effector of GADD45G in senescence induction and growth inhibition of liver tumor cells.
    Xu G; Zhang L; Ma A; Qian Y; Ding Q; Liu Y; Wang B; Yang Z; Liu Y
    Oncotarget; 2015 Oct; 6(32):33636-47. PubMed ID: 26378039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.
    Zhang L; Yang Z; Ma A; Qu Y; Xia S; Xu D; Ge C; Qiu B; Xia Q; Li J; Liu Y
    Hepatology; 2014 Jan; 59(1):178-89. PubMed ID: 23897841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Methoxydalbergione is a potent inhibitor of human astroglioma U87 cells in vitro and in vivo.
    Li R; Xu CQ; Shen JX; Ren QY; Chen DL; Lin MJ; Huang RN; Li CH; Zhong RT; Luo ZH; Ji XY; Wu J
    Acta Pharmacol Sin; 2021 Sep; 42(9):1507-1515. PubMed ID: 33311599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
    Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
    J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.
    Pang YY; Li JD; Gao L; Yang X; Dang YW; Lai ZF; Liu LM; Yang J; Wu HY; He RQ; Huang ZG; Xiong DD; Yang LH; Shi L; Mo WJ; Tang D; Lu HP; Chen G
    Cancer Med; 2020 Nov; 9(21):8004-8019. PubMed ID: 32931665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
    Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
    Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression characteristics and clinical significance of ACP6, a potential target of nitidine chloride, in hepatocellular carcinoma.
    Gao L; Xiong DD; Yang X; Li JD; He RQ; Huang ZG; Lai ZF; Liu LM; Luo JY; Du XF; Zeng JH; Li MF; Li SH; Dang YW; Chen G
    BMC Cancer; 2022 Dec; 22(1):1244. PubMed ID: 36456931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
    Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
    Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.
    Peng R; Zhao GX; Li J; Zhang Y; Shen XZ; Wang JY; Sun JY
    World J Gastroenterol; 2016 Mar; 22(12):3341-54. PubMed ID: 27022216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 15. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Guo W; Zhu T; Dong Z; Cui L; Zhang M; Kuang G
    Clin Exp Metastasis; 2013 Dec; 30(8):977-92. PubMed ID: 23793925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1.
    Wang W; Zhang H; Wang L; Zhang S; Tang M
    Biochem Biophys Res Commun; 2016 May; 473(4):987-992. PubMed ID: 27049311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
    Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
    PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
    Shin S; Kim M; Lee SJ; Park KS; Lee CH
    Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.